Medpace Holdings (MEDP) Equity Ratio (2015 - 2026)

Medpace Holdings (MEDP) has reported Equity Ratio for 12 consecutive years, with 0.28 the latest figure, recorded in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.28, down 10.2% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.28 (down 10.2% YoY), and the FY2025 annual result was 0.23, down 40.86% from the prior year.
• Equity Ratio was 0.28 for Q1 2026 at Medpace Holdings, up from 0.23 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.45 in Q1 2022 and troughed at 0.11 in Q2 2025.
• Average Equity Ratio over 5 years is 0.3, with a median of 0.29 recorded in 2022.
• Year-over-year, Equity Ratio soared 50.3% in 2024 and plunged 72.43% in 2025.
• Over 5 years, Equity Ratio stood at 0.29 in 2022, then climbed by 18.09% to 0.34 in 2023, then grew by 16.48% to 0.39 in 2024, then sank by 40.86% to 0.23 in 2025, then advanced by 20.9% to 0.28 in 2026.
• Per Business Quant data, the three most recent Equity Ratio figures were 0.28 in Q1 2026, 0.23 in Q4 2025, and 0.17 in Q3 2025.